Naringenin and naringin in cardiovascular disease prevention: A preclinical review.

Naringenin and naringin in cardiovascular disease prevention: A preclinical review.
Eur J Pharmacol. 2020 Sep 07;:173535
Authors: Moghaddam RH, Samimi Z, Moradi SZ, Little PJ, Xu S, Farzaei MH
Abstract
Cardiovascular disease is an important cause for morbidity and mortality worldwide. Flavonoids, such as naringin, and naringenin are important natural phytochemicals in the treatment or prevention of various disorders such as obesity, cardiac diseases, diabetes, and metabolic syndrome. Naringin and naringenin have significant therapeutic potential in several diseases through anti-oxidative, anti-inflammatory, and anti-apoptotic actions; these flavonoids play a protective role in human pathophysiology. In this review, based on the latest evidence, we present a summary of the impact of naringin, and naringenin on cardiovascular disease, and analyze and discuss the basic roles of naringin and naringenin and their mechanisms of actions in cardiovascular disease and other vascular dysfunction. The data collected in this review may serve as a comprehensive reference for the effects of naringin, and naringenin in cardiovascular disease, which may be beneficial for further research and for the design of naringin and naringenin analogs as new therapeutic options for cardiovascular diseases.
PMID: 32910944 [PubMed - as supplied by publisher]

Source: European Journal of Pharmacology - September 6, 2020 Category: Drugs & Pharmacology Authors: Moghaddam RH, Samimi Z, Moradi SZ, Little PJ, Xu S, Farzaei MH Tags: Eur J Pharmacol Source Type: research